EpiVax and FDA Unveil New Insights on Generic Teriparatide Risks EpiVax, in collaboration with the FDA, reveals findings on immunogenicity risks linked to impurities in generic teriparatide, ensuring drug safety.

EpiVax and FDA Unveil New Insights on Generic Teriparatide Risks #USA #FDA #Providence #EpiVax #Teraparatide